Aljohani R, Alenzi F, Aboabat A et al (2025) Disease characteristics and outcomes of lupus nephritis in Saudi Arabia: A systematic review. Lupus 34:1184–1198. https://doi.org/10.1177/09612033251360628

Article  PubMed  CAS  Google Scholar 

Jakes RW, Bae S, Louthrenoo W et al (2012) Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: Prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) 64:159–168. https://doi.org/10.1002/acr.20683

Article  PubMed  Google Scholar 

Fatoye F, Gebrye T, Mbada C (2022) Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis. Rheumatol Int 42:2097–2107. https://doi.org/10.1007/s00296-022-05183-4

Article  PubMed  PubMed Central  Google Scholar 

Al Arfaj A, Khalil N (2009) Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 18:465–473. https://doi.org/10.1177/0961203308100660

Article  PubMed  CAS  Google Scholar 

Alenzi F, Ateka-Barrutia O, Ken Cheah C et al (2024) Lupus Nephritis Outcomes after Stopping Immunosuppression. J Clin Med 13:2211. https://doi.org/10.3390/jcm13082211

Article  PubMed  PubMed Central  CAS  Google Scholar 

Moroni G, Longhi S, Giglio E et al (2013) What happens after complete withdrawal of therapy in patients with lupus nephritis. Clin Exp Rheumatol 31:S75–81

PubMed  Google Scholar 

Moroni G, Gallelli B, Quaglini S et al (2006) Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up. Nephrol Dialysis Transplantation 21:1541–1548. https://doi.org/10.1093/ndt/gfk073

Article  CAS  Google Scholar 

Jeon H, Lee J, Moon S-J et al (2024) Predictors of renal relapse in Koreans with lupus nephritis after achieving complete response: a 35-years of experience at a single center. Korean J Intern Med 39:347–359. https://doi.org/10.3904/kjim.2023.255

Article  PubMed  PubMed Central  Google Scholar 

Fanouriakis A, Kostopoulou M, Anders H-J et al (2025) EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update. https://doi.org/10.1016/j.ard.2025.09.007. Ann Rheum Dis

Rovin BH, Ayoub IM, Chan TM et al (2024) KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS. Kidney Int 105:S1–S69. https://doi.org/10.1016/j.kint.2023.09.002

Article  Google Scholar 

Sammaritano LR, Askanase A, Bermas BL et al (2025) 2024 American College of Rheumatology (< scp>ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Rheumatol 77:1115–1135. https://doi.org/10.1002/art.43212

Article  PubMed  Google Scholar 

Jourde-Chiche N, Costedoat-Chalumeau N, Baumstarck K et al (2022) Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial. Ann Rheum Dis 81:1420–1427. https://doi.org/10.1136/annrheumdis-2022-222435

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jourde-Chiche N, Bobot M, Burtey S et al (2023) Weaning Maintenance Therapy in Lupus Nephritis: For Whom, When, and How? Kidney Int Rep 8:1481–1488. https://doi.org/10.1016/j.ekir.2023.05.012

Article  PubMed  PubMed Central  Google Scholar 

AlMutairi A, Al-Mayouf SM, Kari J et al (2023) Practice Patterns and Approach to Childhood Lupus Nephritis in Saudi Arabia. Saudi J Kidney Dis Transpl 34:576–591. https://doi.org/10.4103/sjkdt.sjkdt_215_23

Article  PubMed  Google Scholar 

Ibrahim ST, Edwards CJ, Ehrenstein MR et al (2023) Differences in management approaches for lupus nephritis within the UK. Rheumatol Adv Pract 8. https://doi.org/10.1093/rap/rkae017

Zimba O, Gasparyan AY (2023) Designing, Conducting, and Reporting Survey Studies: A Primer for Researchers. J Korean Med Sci 38. https://doi.org/10.3346/jkms.2023.38.e403

Fanouriakis A, Kostopoulou M, Andersen J et al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83:15–29. https://doi.org/10.1136/ard-2023-224762

Article  PubMed  CAS  Google Scholar 

Panagiotopoulos A, Kapsia E, El Michelakis I et al (2025) Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes. Rheumatology 64:1894–1903. https://doi.org/10.1093/rheumatology/keae381

Article  PubMed  PubMed Central  Google Scholar 

Pitsigavdaki S, Nikoloudaki M, Garantziotis P et al (2024) Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Ann Rheum Dis 83:464–474. https://doi.org/10.1136/ard-2023-224919

Article  PubMed  PubMed Central  Google Scholar 

Cho J, Shen L, Huq M et al (2023) Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study. Lancet Rheumatol 5:e584–e593. https://doi.org/10.1016/S2665-9913(23)00209-6

Article  PubMed  CAS  Google Scholar 

Vidal-Montal P, Narváez J, Fulladosa X et al (2025) Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis. Lupus Sci Med 12:e001375. https://doi.org/10.1136/lupus-2024-001375

Article  PubMed  PubMed Central  Google Scholar 

Malvar A, Alberton V, Lococo B et al (2020) Kidney biopsy–based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis. Kidney Int 97:156–162. https://doi.org/10.1016/j.kint.2019.07.018

Article  PubMed  CAS  Google Scholar 

De Rosa M, Azzato F, Toblli JE et al (2018) A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy. Kidney Int 94:788–794. https://doi.org/10.1016/j.kint.2018.05.021

Article  PubMed  Google Scholar 

Malvar A, Pirruccio P, Alberton V et al (2017) Histologic versus clinical remission in proliferative lupus nephritis. Nephrol Dialysis Transplantation 32:1338–1344. https://doi.org/10.1093/ndt/gfv296

Article  CAS  Google Scholar 

Ohmura K, Shimizu H, Tanaka Y et al (2025) Impact of glucocorticoid tapering speed on renal outcomes in proliferative lupus nephritis: a multicentre retrospective study. Rheumatology 64:5014–5022. https://doi.org/10.1093/rheumatology/keaf243

Article  PubMed  CAS  Google Scholar 

Michelakis IE, Panagiotopoulos A, Kapsia E et al (2025) Predictors of a successful glucocorticoid tapering and withdrawal in an inception cohort of patients with lupus nephritis and associations with long-term outcomes and damage accrual. RMD Open 11:e005877. https://doi.org/10.1136/rmdopen-2025-005877

Article  PubMed  PubMed Central  Google Scholar 

Kandinata SG, Awalia, Yuliasih et al (2025) Immunosuppressive therapy withdrawal in lupus nephritis, is it possible? A systematic review. Lupus 34:1003–1012. https://doi.org/10.1177/09612033251352709

Article  PubMed  Google Scholar 

van Vollenhoven RF, Bertsias G, Doria A et al (2021) 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 8:e000538. https://doi.org/10.1136/lupus-2021-000538

Article  PubMed  PubMed Central  Google Scholar 

Aptekar RG JLDADS (1972) Exacerbation of SLE Nephritis after Cyclophosphamide Withdrawal. N Engl J Med 286:1159–1160. https://doi.org/10.1056/NEJM197205252862116

Article  PubMed  CAS  Google Scholar 

Sharon E, Kaplan D, Diamond HS (1973) Exacerbation of Systemic Lupus Erythematosus after Withdrawal of Azathioprine Therapy. N Engl J Med 288:122–124. https://doi.org/10.1056/NEJM197301182880303

Article  PubMed  CAS  Google Scholar 

van Mulligen E, Weel AE, Hazes JM et al (2020) Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial. Ann Rheum Dis 79:1174–1181. https://doi.org/10.1136/annrheumdis-2020-217485

Article  PubMed  PubMed Central  CAS